SNDA (45) HCSG (70) ARDT (67) MD (74) ⌘ Pro Terminal →

Community Health Systems Inc. (CYH) — RQD Stock Rating Cockpit

Q: Should I buy, hold, or sell CYH stock right now?

Community Health Systems Inc. (CYH) currently earns a Roarable Rating of D (Sell — SELL) with 46/100 RQD Confidence. Stretched risk/reward at current multiples (14% return on capital) under elevated 10-year interest-rate pressure.

Q: What is CYH's 12-month price target and RQD AI Jury consensus?

CYH's 12-month base price target is $2.28 (range $1.78 to $4.13), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

$2.41 -9.40% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.36

Community Health Systems Inc. (CYH) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D • SELL / AVOID Cap $339.8M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.36 (-1.88%)🧬 Cannibal Buyback (-0.96% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 1.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-5.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CYH)Realized 20D OHLCV Swing Band: ±10.5%

Deterministic 5-Pillar Attribution (46/100 Composite)

🔍 WHY CYH SCORES 46/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (26% of score)

Altman Z-Score 1.05 (DISTRESS RISK (<1.8)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+11/20 pts (24% of score)

SEC Form 4 / 13F Thermometer: 55% Net Buy • Cannibal Buyback (-0.96% YoY Shares)

▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$2.76+4.3% Next Q

Q2 (-2Q)

Grade C-$2.88+1.4% Next Q

Q3 (-1Q)

Grade D$2.92-17.5% Next Q

Current

Grade D$2.41-6.1% Hist 90D α

Trajectory: C- (54) → D (46)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CYH Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CYH currently carries a cautious 46/100 (D) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.87) and Max Pain ($2.53) forces dealer call-delta covering toward $4.13.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Cannibal Buyback (-0.96% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CYH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CYH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 46%NO 54%Trade / Inspect Odds →

RSI-14 MOMENTUMOVERSOLD (<32)

29.130 Oversold · 70 Hot

ALTMAN-Z SHIELDDISTRESS RISK (<1.8)

1.05>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE13% OF RANGE

L: $2$2.41H: $4

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 8 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: D-RQD 16 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 22 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bearish Warning on CYH

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (40)

13.5% ROIC with 85.1% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (60)

Altman-Z 1.05 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (43)

16/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like CYH

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CYH)

✓Walkthrough of CYH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CYH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -15.14%▼ SUPPORT BREAKDOWN

2026-10-30O $2.33H $2.44L $2.32C $2.41VOL 2.49M

RES: $3.11SUP: $2.52SMA50: $2.87SMA200: $3.03

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CYH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CYH Butterfly Map → + Track CYH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-7.0%/yr Implied 5Y Growth

vs. -1.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CYH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CYH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CYH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CYH)

Health Care Rank #452 of 1016 ⚔️ SNDA vs CYH Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CYH vs. SNDA, HCSG, ARDT, MD)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Community Health Systems Inc. (CYH) ranks #452 by composite RQD confidence (46/100, grade D) and #506 by equity capitalization ($339.8M). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently holds the highest overall quantitative score in the immediate peer group at 74/100 (B) compared with CYH at 46/100 (D).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CYH ACTIVE Community Health Systems Inc.	D	46/100	—	85.1%	13.5%	-9.40%	$339.8M	Benchmark Subject
SNDA Sonida Senior Living Inc.	D	45/100	—	—	—	+1.94%	$1.65B	/snda-vs-cyh →
HCSG Healthcare Services Group Inc.	B-	70/100	28.2x	13.0%	11.6%	+2.58%	$1.66B	/hcsg-vs-cyh →
ARDT Ardent Health Inc.	C+	67/100	12.8x	—	10.5%	+3.10%	$1.73B	/ardt-vs-cyh →
MD Pediatrix Medical Group Inc.	B	74/100	14.3x	—	33.6%	+0.93%	$2.37B	/md-vs-cyh →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001108109

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Community Health Systems Inc. (CYH) reported GAAP revenue of $12.48B (-1.2% vs. FY2024 revenue of $12.63B , and -0.0% cumulative change since FY2023) , GAAP net income of $509.0M, operating cash flow of $543.0M, and free cash flow of $208.0M (+73.3% YoY). On the balance sheet, CYH closed FY2025 with $13.20B in total assets against $10.38B in total debt (Altman Z-Score: 1.05, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$12.48B	$509.0M	$543.0M	$208.0M	$13.20B	$10.38B
FY2024 (FY)	2024-12-31	$12.63B	-$516.0M	$480.0M	$120.0M	$14.05B	$11.43B
FY2023 (FY)	2023-12-31	$12.49B	-$133.0M	$210.0M	$210.0M	—	—

3. CYH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CYH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Community Health Systems Inc. (NYSE: CYH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $2.41 (-9.40% 1D, market cap $339.8M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 11/20. Across 1016 tracked Health Care issuers, CYH ranks #452 in composite RQD confidence.

How does CYH compare to SNDA and HCSG in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), CYH carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 85.1%, and ROIC of 13.5%. By comparison, SNDA (Sonida Senior Living Inc.) holds a D grade (45/100 RQD, P/E N/A, ROIC —, cap $1.65B) and HCSG (Healthcare Services Group Inc.) posts a B- grade (70/100 RQD, P/E 28.2x, ROIC 11.6%, cap $1.66B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CYH?

Per CYH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001108109), Community Health Systems Inc. generated $12.48B in revenue (-1.2% YoY), $509.0M in net income, and $208.0M in free cash flow against $13.20B in total assets and $10.38B in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CYH trading relative to its 50-day, 200-day, and 52-week technical levels?

CYH last traded at $2.41 (-9.40% on volume of 8,035,342 shares), positioning the stock -16.03% below its 50-day simple moving average ($2.87) and -20.46% below its 200-day simple moving average ($3.03). Across its 52-week range of $2.19 to $3.93, CYH sits at the 12.6% percentile with a 14-day RSI of 29.1 (OVERSOLD (<32)) and an implied next-earnings move of ±10.5% ($2.16 to $2.66).

CYH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell CYH stock right now?

Community Health Systems Inc. (CYH) currently earns a Roarable Rating of D (Sell — SELL) with 46/100 RQD Confidence. Stretched risk/reward at current multiples (14% return on capital) under elevated 10-year interest-rate pressure.

What is CYH's 12-month price target and RQD AI Jury consensus?

CYH's 12-month base price target is $2.28 (range $1.78 to $4.13), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: CYH RQD Cockpit CYH 12M Forecast CYH Earnings & Move CYH Dividends & DRIP CYH Insiders & 13F CYH Whale Options CYH Profit Sankey CYH News & Why